EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Recent developments in understanding RIG-I's activation and oligomerization

Justyna Sikorska iD, Daniel F Wyss iD

Science Progress · 2024

DOI: 10.1177/00368504241265182 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Science Progress, 2024. Verfasst von Justyna Sikorska und 1 weiteren Autor:innen. Beteiligte Einrichtung: Merck & Co., Inc., Rahway, NJ, USA. Hauptthemen laut MEDLINE: DEAD Box Protein 58, Receptors, Immunologic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Merck.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Insights into mechanisms driving either activation or inhibition of immune response are crucial in understanding the pathology of various diseases. The differentiation of viral from endogenous RNA in the cytoplasm by pattern-recognition receptors, such as retinoic acid-inducible gene I (RIG-I), is one of the essential paths for timely activation of an antiviral immune response through induction of type I interferons (IFN). In this mini-review, we describe the most recent developments centered around RIG-I's structure and mechanism of action. We summarize the paradigm-changing work over the past few years that helped us better understand RIG-I's monomeric and oligomerization states and their role in conveying immune response. We also discuss potential applications of the modulation of the RIG-I pathway in preventing autoimmune diseases or induction of immunity against viral infections. Overall, our review aims to summarize innovative research published in the past few years to help clarify questions that have long persisted around RIG-I.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DEAD Box Protein 58Receptors, ImmunologicHumansAnimalsVirus DiseasesInterferon Type ISignal TransductionProtein MultimerizationImmunity, Innate

Stichwörter der Autor:innen

RIG-IRNARNA-binding proteinsantiviral immune responsestructural flexibility of RIG-I

Substanzen

DEAD Box Protein 58Receptors, ImmunologicRIGI protein, humanInterferon Type I

Autor:innen und Institutionen

  • Merck & Co., Inc., Rahway, NJ, USA.

ORCID-Profile: Justyna Sikorska, Daniel F Wyss

Förderung

  • Merck

Zitieren

APA

Sikorska, J., & Wyss, D. F. (2024). Recent developments in understanding RIG-I's activation and oligomerization. Science Progress. https://doi.org/10.1177/00368504241265182

Vancouver

Sikorska J, Wyss DF. Recent developments in understanding RIG-I's activation and oligomerization. Science Progress. 2024. doi:10.1177/00368504241265182

BibTeX
@article{Sikorska2024,
  author = {Sikorska, Justyna and Wyss, Daniel F},
  title = {Recent developments in understanding RIG-I's activation and oligomerization},
  journal = {Science Progress},
  year = {2024},
  doi = {10.1177/00368504241265182}
}
Kostenlos starten →